The Clinical and Translational Science Collaborative (CTSC) Resources and Services (R&S) Voucher Program is intended to promote collaboration among the various partner institutions of the CTSC and designed to support investigators in the acquisition of preliminary data or other project components for grant submission.
Projects must be multi-institutional, where at least two (2) CTSC partner institutions are involved -OR- one (1) CTSC partner institution and one (1) community partner are involved.
Projects that involve late-stage clinical and translational research (T3-T4*), early-stage investigators, Diversity, Equity, Inclusion, and Accessibility (DEIA), and Dissemination & Implementation (D&I) will be prioritized.
Studies conducted outside the United States, as well as those funded by pharmaceutical companies or other industries, are not eligible for a CTSC Voucher award.
Voucher awards are to be used for necessary costs (including eligible CTSC services), up to $7,500, and are limited to one (1) voucher award per project. Please note: Principal Investigators (PIs) can only hold one active voucher at a time and must use all funds before applying for another. Vouchers cannot be reserved for future use or transferred to other projects, researchers, or expenses. Each application can propose using one or more services.
For a list of Voucher Program offerings through the CTSC, see the Voucher Services Catalog linked on this page.
Funding Priorities
- Studies that use at least two (2) CTSC partner institutions
- New/early-stage investigators pursuing extramural grant funding
- Investigators with diverse/underserved backgrounds
- Voucher funding will be focused on late-stage clinical and translational research (T3-T4*), including the use of human samples.
- Early-stage investigators (or those with new research direction) pursuing high priority areas for our CTSC, namely health disparities and Dissemination & Implementation (D&I).
- Early-stage investigators conducting an investigator-initiated study that is anticipated to lead to extramural grant funding.
- Investigators who have not previously been awarded a voucher.
Voucher Criteria
PI(s) in good standing (ie. Required institutional training for research and reporting of Conflicts of Interest) with a primary appointment at CWRU, Cleveland Clinic, MetroHealth Medical Center, University Hospitals Cleveland Medical Center, The Louis Stokes Cleveland VA Medical Center, Northeast Ohio Medical University and/or University of Toledo are eligible to apply for vouchers.
The study project must align with at least one of our central CTSC goals. These goals include:
1. Identify the fundamental barriers to optimal recruitment of underrepresented groups in clinical trials, innovate, test and disseminate interventions aimed at breaking down these barriers to diversify study engagement and close the health disparities gap.
2. Facilitate and expedite innovation in multicenter clinical and translational research by fully integrating community and stakeholder partners to ensure that our research results in health improvements for all.
3. Disseminate and implement findings from novel and responsive research programs across clinical and community settings to advance access to health interventions that aim to promote health equity.
4. Create and disseminate inclusive and high impact educational and training programs for translational research professionals of all disciplines and levels, both in clinical and community settings
While the research project does not need to be fully completed within the award period, project activities supported by vouchers must be expended within 3 months of the award letter’s designated date.*
*Special cases can apply for 3-month extension. Please contact a Voucher Administrator for further information.
Application Components |
Criteria |
Research Navigator Review - Meets Voucher Requirements (If any of these requirements are not met, the application will receive an automatic return and encouraged to resubmit) |
|
1-page Research Proposal Elements |
|
Project Overview
Hypothesis, rationale, aims, research plan/methods & innovation/translational impact |
The project’s research question/hypothesis, specific aims, and research plan/methods are clearly articulated and easy to understand. Each institution's and investigator's responsibilities are well-defined, ensuring clarity in roles. Additionally, the project’s potential impact is clearly indicated. |
The Project Scientific Advancements and Dissemination |
The project will build research capacity and further advance science through publication of a peer-reviewed manuscript, preliminary data with grant submission proposed and/or a presentation at a nationally/internationally recognized conference, and/or support larger funding opportunities. |
Activities and Time Frame |
Project services/activities requested for funding will be completed within 3 months of award letter*. Projects utilizing voucher funds for regulatory support (e.g. IRB, IND/IDE, FDA) must have regulatory application submitted within the 3-month period. Projects that require IRB approval to get started with services/activities supported by the voucher program must have IRB application already submitted prior to applying for a Voucher. |
Budget and Funding Utilization |
Itemized quote includes the cost of each service (e.g., flat rate or hourly rate), contact information for the financial representative, and contact information for the investigator or the individual for whom the services are intended. Quote cannot include support for Principal Investigator salary. |
Application Process
Vouchers will be reviewed and allocated on a rolling basis based on the requested amount (see Table 1 for review and turnaround times).
Table 1. Voucher Awards and Review Turnaround Times |
||
Requested Amount |
$0 to $5,000 |
> $5,000 to $7,500 |
Review by |
R&S Admins |
R&S Module Leads |
Turnaround |
3-5 days |
2-4 weeks |
**if additional review by Subject Matter Expert(s) is deemed necessary
Translational Spectrum:
- T1 seeks to move basic discovery into a candidate health application. Research examples include: human physiology, first in humans (healthy volunteers), proof of concept, Phase 1 Clinical Trials.
- T2 assesses the value of application for health practice leading to the development of evidence-based guidelines. Research examples include: Phase 2 and Phase 3 Clinical Trials.
- T3 attempts to move evidence-based guidelines into health practice, through delivery, dissemination, and diffusion research. Research examples include health services research related to dissemination, communication, and implementation, and clinical outcomes research.
- T4 seeks to evaluate the “real world” health outcomes of population health practice. Research examples include: population level outcome studies; studies of the social determinants of health.